These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19493658)
1. Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients. Shiloh R; Schapir L; Bar-Ziv D; Stryjer R; Konas S; Louis R; Hermesh H; Munitz H; Weizman A; Valevski A Eur Neuropsychopharmacol; 2009 Sep; 19(9):654-8. PubMed ID: 19493658 [TBL] [Abstract][Full Text] [Related]
2. Corneal temperature in schizophrenia patients. Shiloh R; Munitz H; Portuguese S; Gross-Isseroff R; Sigler M; Bodinger L; Katz N; Stryjer R; Hermesh H; Weizman A Int J Neuropsychopharmacol; 2005 Dec; 8(4):537-47. PubMed ID: 15927092 [TBL] [Abstract][Full Text] [Related]
3. A significant correlation between ward temperature and the severity of symptoms in schizophrenia inpatients--a longitudinal study. Shiloh R; Munitz H; Stryjer R; Weizman A Eur Neuropsychopharmacol; 2007; 17(6-7):478-82. PubMed ID: 17234387 [TBL] [Abstract][Full Text] [Related]
4. Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patients. Shiloh R; Bodinger L; Katz N; Sigler M; Stryjer R; Hermesh H; Munitz H; Weizman A Neuropsychobiology; 2003; 48(1):1-4. PubMed ID: 12886032 [TBL] [Abstract][Full Text] [Related]
5. Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study. Krivoy A; Weizman A; Laor L; Hellinger N; Zemishlany Z; Fischel T Eur Neuropsychopharmacol; 2008 Feb; 18(2):117-21. PubMed ID: 17728110 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p.r.n. medication. Chaichan W J Psychiatr Pract; 2008 Mar; 14(2):105-13. PubMed ID: 18360196 [TBL] [Abstract][Full Text] [Related]
8. Interictal psychoses in comparison with schizophrenia--a prospective study. Tadokoro Y; Oshima T; Kanemoto K Epilepsia; 2007 Dec; 48(12):2345-51. PubMed ID: 17666070 [TBL] [Abstract][Full Text] [Related]
9. In vivo occipital-frontal temperature-gradient in schizophrenia patients and its possible association with psychopathology: a magnetic resonance spectroscopy study. Shiloh R; Kushnir T; Gilat Y; Gross-Isseroff R; Hermesh H; Munitz H; Stryjer R; Weizman A; Manor D Eur Neuropsychopharmacol; 2008 Aug; 18(8):557-64. PubMed ID: 18554876 [TBL] [Abstract][Full Text] [Related]
10. Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder. Nolan KA; Volavka J; Czobor P; Sheitman B; Lindenmayer JP; Citrome LL; McEvoy J; Lieberman JA J Psychiatr Res; 2005 Jan; 39(1):109-15. PubMed ID: 15504429 [TBL] [Abstract][Full Text] [Related]
11. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status. Putzhammer A; Perfahl M; Pfeiff L; Hajak G Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585 [TBL] [Abstract][Full Text] [Related]
12. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample]. Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371 [TBL] [Abstract][Full Text] [Related]
13. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients. Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448 [TBL] [Abstract][Full Text] [Related]
14. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918 [TBL] [Abstract][Full Text] [Related]
15. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics. Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116 [TBL] [Abstract][Full Text] [Related]
16. The temporal relationship between symptom change and treatment discontinuation in a pooled analysis of 4 schizophrenia trials. Kinon BJ; Ascher-Svanum H; Adams DH; Chen L J Clin Psychopharmacol; 2008 Oct; 28(5):544-9. PubMed ID: 18794651 [TBL] [Abstract][Full Text] [Related]
17. Increased corneal temperature in drug-free male schizophrenia patients. Shiloh R; Portuguese S; Bodinger L; Katz N; Sigler M; Hermesh H; Munitz H; Weizman A Eur Neuropsychopharmacol; 2003 Jan; 13(1):49-52. PubMed ID: 12480122 [TBL] [Abstract][Full Text] [Related]
18. Elevation of the cortisol/dehydroepiandrosterone ratio in schizophrenia patients. Ritsner M; Maayan R; Gibel A; Strous RD; Modai I; Weizman A Eur Neuropsychopharmacol; 2004 Aug; 14(4):267-73. PubMed ID: 15163435 [TBL] [Abstract][Full Text] [Related]